Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors
Abstract:
The present disclosure provides compounds represented by Formula I and II: and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, X, W, Y, and Z are as defined as set forth in the specification. The present disclosure also provides compounds of Formula I and II for use to treat a condition or disorder responsive to LSD1 inhibition such as cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0